Drug intelligence / Profile preview

methasterone

Development stage
Unknown
Lead developer
Designer Supplements
Modality
Small Molecules
Administration
Oral
01

Overview

Superdrol is the brand name for methasterone (also known as methyldrostanolone), a synthetic and orally active anabolic-androgenic steroid (AAS). It is a 17α-methylated derivative of drostanolone, designed to be orally bioavailable while maintaining high anabolic potency. The compound acts as an agonist of the androgen receptor, primarily in skeletal muscle tissue, to promote significant increases in muscle mass and strength. Originally introduced in 2005 by Designer Supplements as a "designer supplement," it was never approved for medical use by the FDA and was eventually banned and classified as a Schedule III controlled substance in 2012 due to its potential for abuse and hepatotoxicity. While the brand name is currently used for other products, the original Superdrol refers specifically to the methasterone compound.

Brand names
Superdrol
Other names
methyldrostanolone2α,17α-dimethyl-5α-androstane-3-one-17β-ol17α-methyldrostanolone
02

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on methasterone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methasterone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call